Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lipocine (LPCN) FCF Margin (2018 - 2025)

Lipocine's FCF Margin history spans 8 years, with the latest figure at 2605.93% for Q3 2025.

  • For Q3 2025, FCF Margin changed N/A year-over-year to 2605.93%; the TTM value through Sep 2025 reached 119.12%, down 5298.0%, while the annual FY2024 figure was 11.71%, 40498.0% up from the prior year.
  • FCF Margin reached 2605.93% in Q3 2025 per LPCN's latest filing, down from 302.84% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 5888.93% in Q1 2021 to a low of 12692.34% in Q3 2021.
  • Average FCF Margin over 5 years is 1232.38%, with a median of 193.16% recorded in 2025.
  • Peak YoY movement for FCF Margin: plummeted -472653bps in 2022, then surged 718210bps in 2024.
  • A 5-year view of FCF Margin shows it stood at 55.92% in 2021, then crashed by -1193bps to 611.33% in 2022, then skyrocketed by 254bps to 939.68% in 2023, then crashed by -95bps to 48.46% in 2024, then plummeted by -5478bps to 2605.93% in 2025.
  • Per Business Quant, the three most recent readings for LPCN's FCF Margin are 2605.93% (Q3 2025), 302.84% (Q2 2025), and 2097.99% (Q1 2025).